Characteristics of care provided for severe PPH, 2005 to 2008, in the 2 units
Characteristics of care provided for severe PPH, 2005 to 2008, in the 2 units
Level II Unit | 2005
|
2006
|
2007
|
2008
|
P* | ||||
---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | ||
| |||||||||
32 | 100 | 9 | 100 | 8 | 100 | 11 | 100 | ||
▪ Global quality of care | |||||||||
Optimal care | 15 | 47 | 8 | 88 | 5 | 63 | 8 | 73 | 0.1 |
Sub-optimal care | 17 | 53 | 1 | 22 | 3 | 37 | 3 | 27 | |
Non-optimal care | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
▪ Specific components of management | |||||||||
All Severe PPH | 32 | 100 | 9 | 100 | 8 | 100 | 11 | 100 | |
Administration of oxytocin | 27 | 84 | 9 | 100 | 8 | 100 | 11 | 100 | 0.8 |
Call for additional staff | 28 | 88 | 8 | 89 | 8 | 100 | 10 | 91 | 0.9 |
Severe PPH at vaginal delivery | 21 | 100 | 6 | 100 | 3 | 100 | 8 | 100 | |
Pharmacological prophylaxis | 10 | 48 | 5 | 83 | 2 | 67 | 7 | 88 | 0.1 |
Examination of the uterine cavity | 15 | 71 | 6 | 100 | 2 | 67 | 6 | 75 | 0.8 |
within 15 minutes of PPH diagnosis | 9 | 43 | 5 | 83 | 2 | 67 | 5 | 63 | 0.6 |
Instrumental examination of vagina/cervix | 5 | 24 | 6 | 100 | 3 | 100 | 7 | 88 | <0.01 |
Severe PPH due to uterine atony | 21 | 100 | 7 | 100 | 7 | 100 | 6 | 100 | |
Intravenous administration of sulprostone | 8 | 38 | 6 | 86 | 6 | 86 | 5 | 83 | 0.1 |
within 30 min of PPH diagnosis | 6 | 29 | 6 | 86 | 5 | 71 | 5 | 83 | 0.05 |
| |||||||||
Level III Unit | n | % | n | % | n | % | n | % | P* |
| |||||||||
45 | 100 | 41 | 100 | 33 | 100 | 31 | 100 | ||
▪ Global quality of care | |||||||||
Optimal care | 10 | 22 | 9 | 22 | 14 | 42 | 19 | 61 | <0.01 |
Sub-optimal care | 24 | 53 | 27 | 66 | 18 | 55 | 11 | 35 | |
Non-optimal care | 11 | 24 | 5 | 12 | 1 | 3 | 1 | 4 | |
▪ Specific components of management | |||||||||
All Severe PPH | 45 | 100 | 41 | 100 | 33 | 100 | 31 | 100 | |
Administration of oxytocin | 43 | 96 | 36 | 88 | 32 | 97 | 31 | 100 | 0.9 |
Call for additional staff | 43 | 96 | 41 | 100 | 31 | 94 | 30 | 97 | 0.9 |
Severe PPH at vaginal delivery | 27 | 100 | 25 | 100 | 16 | 100 | 9 | 100 | |
Pharmacological prophylaxis | 5 | 19 | 18 | 72 | 10 | 63 | 9 | 100 | <0.01 |
Examination of the uterine cavity | 19 | 70 | 23 | 92 | 16 | 100 | 8 | 89 | 0.5 |
within 15 minutes of PPH diagnosis | 7 | 26 | 22 | 88 | 10 | 63 | 8 | 89 | <0.01 |
Instrumental examination of vagina/cervix | 11 | 41 | 18 | 72 | 9 | 56 | 8 | 89 | 0.03 |
Severe PPH due to uterine atony | 35 | 100 | 29 | 100 | 14 | 100 | 19 | 100 | |
Intravenous administration of sulprostone | 20 | 57 | 25 | 86 | 13 | 93 | 18 | 95 | <0.01 |
within 30 min of PPH diagnosis | 5 | 14 | 16 | 55 | 7 | 50 | 18 | 95 | <0.01 |